Press Release Jun 03 2026

About this update from Granules India Limited

Granules India Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Granules Pharmaceuticals, Inc. Receives USFDA EIR for Chantilly Facility". View Attachment

View stock analysis, news, and events for Granules India Limited